EUVIMEDEUVIMED entdecken
Crossref

Prevalence and Projection of Medicine-Treated Type 2 Diabetes in Greece (2016–2022): Real-World Data from the National prescription database

Spyros Polyzois iD, Panagiota Mitrou, Anastasios Tsolakidis, Nikolaos Papanas iD, Theodoros Constantinides, Christos Kontogiorgis

Experimental and Clinical Endocrinology & Diabetes · 08.09.2026

DOI: 10.1055/a-2937-5128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, online erschienen am 08.09.2026. Verfasst von Spyros Polyzois und 5 weiteren Autor:innen. Beteiligte Einrichtung: Democritus University of Thrace School of Health Sciences, Laboratory of Hygiene and Enviromental Protection, Department of Medicine, Evros, Greece, …. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Since type 2 diabetes is one of the greatest burdens in public health over the past decade, evidence regarding its impact on the Greek population is scarce. To address this situation, the current study aims to reveal epidemiological data on type 2 diabetes in Greece by calculating the annual prevalence between 2016 and 2022 and to investigate trends regarding age and sex factors.

Methods

Real-world prescription data were used from the official database of the e-Government Center for Social Security Services. The study population comprised individuals who were entitled to type 2 diabetes care, with the relevant International Classification of Diseases, 10th Revision code. Descriptive statistics, chi-square tests and regression analysis were performed by calculating prevalence rates, using 2011 official census of Greek population.

Results

Prevalence rates of type 2 diabetes follow an increasing trend, increasing from 7.97% in 2016 to 8.65% in 2022. A similar trend was observed among male and female individuals; the male prevalence rate increased from 8% in 2016 to 8.86% in 2022, whereas the female prevalence rate increased from 7.95% in 2016 to 8.46% in 2022. The prevalence rate ratios between 2016 and 2022 underline the increasing trends of type 2 diabetes in population, as the total prevalence rate ratio was equal to 1.09 (95% confidence interval: 1.08–1.09, p < 0.001). Linear regression revealed the association between the prevalence rate and the sex or age factor.

Conclusions

Type 2 diabetes prevalence in Greece increased between 2016 and 2022, in accordance with the European and International data, with higher rates observed among males and older adults. The marked relative increase among individuals aged 18 to 29 years constitutes an important epidemiological finding and highlights the need for targeted prevention and early intervention strategies.

Autor:innen und Institutionen

  • Democritus University of Thrace School of Health Sciences, Laboratory of Hygiene and Enviromental Protection, Department of Medicine, Evros, Greece, Alexandroupoli.
  • Hellenic Ministry of Health, Independent Department of Therapeutic Protocols and Patient Registries, Attica, Greece, Athens.
  • e-Government Center for Social Security Services (IDIKA), Attica, Greece, Athens.
  • Democritus University of Thrace, Second Department of Internal Medicine, Greece, Alexandroupolis.

ORCID-Profile: Spyros Polyzois, Nikolaos Papanas

Zitieren

APA

Polyzois, S., Mitrou, P., Tsolakidis, A., Papanas, N., Constantinides, T., & Kontogiorgis, C. (2026). Prevalence and Projection of Medicine-Treated Type 2 Diabetes in Greece (2016–2022): Real-World Data from the National prescription database. Experimental and Clinical Endocrinology & Diabetes. https://doi.org/10.1055/a-2937-5128

Vancouver

Polyzois S, Mitrou P, Tsolakidis A, Papanas N, Constantinides T, Kontogiorgis C. Prevalence and Projection of Medicine-Treated Type 2 Diabetes in Greece (2016–2022): Real-World Data from the National prescription database. Experimental and Clinical Endocrinology & Diabetes. 2026. doi:10.1055/a-2937-5128

BibTeX
@article{Polyzois2026,
  author = {Polyzois, Spyros and Mitrou, Panagiota and Tsolakidis, Anastasios and Papanas, Nikolaos and Constantinides, Theodoros and Kontogiorgis, Christos},
  title = {Prevalence and Projection of Medicine-Treated Type 2 Diabetes in Greece (2016–2022): Real-World Data from the National prescription database},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2026},
  doi = {10.1055/a-2937-5128}
}
Kostenlos starten →